Kesavan Sabitha

1.3k total citations
34 papers, 1.1k citations indexed

About

Kesavan Sabitha is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Kesavan Sabitha has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Complementary and alternative medicine. Recurrent topics in Kesavan Sabitha's work include Natural Antidiabetic Agents Studies (5 papers), Computational Drug Discovery Methods (4 papers) and Protein Degradation and Inhibitors (4 papers). Kesavan Sabitha is often cited by papers focused on Natural Antidiabetic Agents Studies (5 papers), Computational Drug Discovery Methods (4 papers) and Protein Degradation and Inhibitors (4 papers). Kesavan Sabitha collaborates with scholars based in India and United States. Kesavan Sabitha's co-authors include C. S. Shyamala Devi, Mallika Jainu, Thangarajan Rajkumar, S. Prabhu, Sundersingh Shirley, Gopal Gopisetty, Neelakantan Vijayalakshmi, G Selvaluxmy, Venugopal P. Menon and N. Nalini and has published in prestigious journals such as Scientific Reports, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Kesavan Sabitha

32 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kesavan Sabitha India 15 388 221 164 154 149 34 1.1k
Hyemee Kim United States 25 622 1.6× 234 1.1× 93 0.6× 148 1.0× 206 1.4× 54 1.5k
Hiromi Shimada Japan 17 575 1.5× 129 0.6× 191 1.2× 176 1.1× 355 2.4× 74 1.3k
Gwi Seo Hwang South Korea 24 702 1.8× 194 0.9× 78 0.5× 235 1.5× 174 1.2× 70 1.4k
Chau-Jong Wang Taiwan 15 388 1.0× 106 0.5× 93 0.6× 257 1.7× 175 1.2× 18 1.2k
Norhafizah Mohtarrudin Malaysia 19 365 0.9× 145 0.7× 133 0.8× 212 1.4× 268 1.8× 66 1.1k
Young Jin Moon South Korea 13 496 1.3× 77 0.3× 108 0.7× 261 1.7× 166 1.1× 25 1.4k
Sukta Das India 19 411 1.1× 151 0.7× 70 0.4× 130 0.8× 247 1.7× 43 1.0k
Nahla E. El‐Ashmawy Egypt 21 380 1.0× 105 0.5× 51 0.3× 154 1.0× 89 0.6× 67 1.1k

Countries citing papers authored by Kesavan Sabitha

Since Specialization
Citations

This map shows the geographic impact of Kesavan Sabitha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesavan Sabitha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesavan Sabitha more than expected).

Fields of papers citing papers by Kesavan Sabitha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kesavan Sabitha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesavan Sabitha. The network helps show where Kesavan Sabitha may publish in the future.

Co-authorship network of co-authors of Kesavan Sabitha

This figure shows the co-authorship network connecting the top 25 collaborators of Kesavan Sabitha. A scholar is included among the top collaborators of Kesavan Sabitha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesavan Sabitha. Kesavan Sabitha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabitha, Kesavan, et al.. (2022). The Immune-related ceRNA Network in Prognosis of Cervical Cancer. Asian Pacific Journal of Cancer Prevention. 23(10). 3347–3354. 2 indexed citations
2.
Natarajan, Aparna, Thangarajan Rajkumar, & Kesavan Sabitha. (2019). Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia. Asian Pacific Journal of Cancer Prevention. 20(11). 3399–3406. 5 indexed citations
3.
Gopisetty, Gopal, et al.. (2018). In silico and in vitro screening of small molecule Inhibitors against SYT-SSX1 fusion protein in synovial sarcoma. Computational Biology and Chemistry. 77. 36–43. 3 indexed citations
4.
Sabitha, Kesavan, et al.. (2018). Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer. Computational Biology and Chemistry. 77. 442–454. 3 indexed citations
5.
Ramachandran, Balaji, Kesavan Sabitha, & Thangarajan Rajkumar. (2016). Molecular modeling and docking of small molecule inhibitors against NEK2. Bioinformation. 12(2). 62–68. 35 indexed citations
6.
Sabitha, Kesavan, et al.. (2015). MOLECULAR MODELLING AND DOCKING STUDIES OF HUMAN ACROSIN BINDING PROTEIN (ACRBP/OY-TES-1). International Journal of Pharmacy and Pharmaceutical Sciences. 7(9). 491–495. 1 indexed citations
7.
Sabitha, Kesavan. (2012). Nilotinib based pharmacophore models for BCR-ABL. Bioinformation. 8(14). 658–663. 4 indexed citations
8.
Sabitha, Kesavan & Thangarajan Rajkumar. (2012). Identification of small molecule inhibitors against UBE2C by using docking studies. Bioinformation. 8(21). 1047–1058. 14 indexed citations
9.
Ramshankar, Vijayalakshmi, et al.. (2012). Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing’s Sarcoma in vitro. BMC Cancer. 12(1). 513–513. 10 indexed citations
10.
Rajkumar, Thangarajan, Kesavan Sabitha, Neelakantan Vijayalakshmi, et al.. (2011). Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer. 11(1). 80–80. 151 indexed citations
11.
Rajkumar, Thangarajan, et al.. (2010). Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell International. 10(1). 45–45. 88 indexed citations
12.
Sabitha, Kesavan, et al.. (2010). Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiology. 34(5). 587–592. 40 indexed citations
13.
Sabitha, Kesavan, et al.. (2008). GST genotypes in head and neck cancer patients and its clinical implications. AFRICAN JOURNAL OF BIOTECHNOLOGY. 7(21). 3853–3859. 11 indexed citations
14.
Devi, Rathinasamy Sheela, Shoba Narayan, G. Vani, et al.. (2007). Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytotherapy Research. 21(8). 762–767. 28 indexed citations
15.
Prabhu, S., Mallika Jainu, Kesavan Sabitha, & C. S. Shyamala Devi. (2006). Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats.. PubMed. 44(3). 209–15. 53 indexed citations
17.
Prabhu, S., Mallika Jainu, Kesavan Sabitha, & C. S. Shyamala Devi. (2006). Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. Journal of Ethnopharmacology. 107(1). 126–133. 92 indexed citations
18.
Prabhu, S., Mallika Jainu, Kesavan Sabitha, & C. S. Shyamala Devi. (2006). Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vascular Pharmacology. 44(6). 519–525. 60 indexed citations
19.
Periasamy, Srinivasan, Kesavan Sabitha, & C. S. Shyamala Devi. (2004). Therapeutic Efficacy of Green Tea Polyphenols on 4-Nitroquinoline-1-Oxide Induced Hepatotoxicity. Journal of Natural Remedies. 4(2). 116–119. 1 indexed citations
20.
Nalini, N., Kesavan Sabitha, P. Viswanathan, & Venugopal P. Menon. (1998). Influence of spices on the bacterial (enzyme) activity in experimental colon cancer. Journal of Ethnopharmacology. 62(1). 15–24. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026